1. Home
  2. MAMA vs TRDA Comparison

MAMA vs TRDA Comparison

Compare MAMA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$15.44

Market Cap

649.2M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$13.41

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAMA
TRDA
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
649.2M
481.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
MAMA
TRDA
Price
$15.44
$13.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$17.80
$20.00
AVG Volume (30 Days)
291.6K
191.2K
Earning Date
04-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$95,420,129.00
$25,421,000.00
Revenue This Year
$40.92
$39.97
Revenue Next Year
$29.52
$50.80
P/E Ratio
$191.75
N/A
Revenue Growth
95.54
N/A
52 Week Low
$6.07
$4.93
52 Week High
$17.85
$13.99

Technical Indicators

Market Signals
Indicator
MAMA
TRDA
Relative Strength Index (RSI) 49.18 61.96
Support Level $15.36 $10.84
Resistance Level $16.87 $13.99
Average True Range (ATR) 0.62 0.77
MACD -0.04 0.04
Stochastic Oscillator 45.07 94.06

Price Performance

Historical Comparison
MAMA
TRDA

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: